Lack of response to monoclonal antibody therapy in neuromyelitis optica

Archives of Neurology

Volumn 68, Issue 9, 2011, Pages 1207-1209

  Qian, Peiqing ^a   Cross, Anne H ^a   Naismith, Robert T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; APHASIA; APNEA; ARM WEAKNESS; ARTICLE; ATAXIA; B LYMPHOCYTE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CERVICAL SPINE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSARTHRIA; DYSESTHESIA; FEMALE; HUMAN; INTUBATION; LETHARGY; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE; URINARY TRACT INFECTION; URINE INCONTINENCE; VISUAL ACUITY;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEUROMYELITIS OPTICA;

EID: 80052768438     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.194     Document Type: Article

References (7)

1. Matiello M, Pittock SJ, Porrata L, Weinshenker BG. Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica [published online March 14, 2011]. Arch Neurol. 2011;68(7):953-955.
2. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology. 2003;60(5):848-853. (Pubitemid 36297372)
3. Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65(11):1443-1448.
4. Coles AJ, Compston DA, Selmaj KW, et al; CAMMS223 Trial Investigators. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008;359(17):1786-1801.
5. Bichuetti DB, Lobato de Oliveira EM, Oliveira DM, Amorin de Souza N, Gabbai AA. Neuromyelitis optica treatment: analysis of 36 patients. Arch Neurol. 2010;67(9):1131-1136.
6. Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol. 2006;63(7):957-963. (Pubitemid 44036296)
7. Kim S-H, Kim W, Park MS, Sohn EH, Li XF, Kim HJ. Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica. Arch Neurol. 2011;68(4):473-479.